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We review original research in the field of critical care
nephrology accepted or published in 2013 in Critical
Care and, when considered relevant or linked to these
studies, in other journals. Three main topics have been
identified and are discussed for a rapid overview:
acute kidney injury (diagnosis, risk factors and
outcome); timing and modality of renal replacement
therapy; and extracorporeal membrane oxygenation
and renal dysfunction.Diagnosis of acute kidney injury
Apart from the specific issue of AKI classification, accur-Introduction
Acute kidney injury (AKI) is a common and severe com-
plication of critical illness associated with death and dis-
ability. The symptoms and clinical consequences of AKI
can be quite similar regardless of whether the etiology is
predominantly within the kidney or predominantly out-
side the kidney; the AKI syndrome encompasses both
structural injury as well as acute functional impairment.
The costs of care for these patients are very high and
research on AKI is thus focusing on prevention, early
detection and treatment. The non-profit foundation
Kidney Disease: Improving Global Outcome (KDIGO),
managed by the National Kidney Foundation with the
aim of developing and implementing guidelines, com-
pleted in 2012 the first international, multidisciplinary,
clinical practice guidelines for AKI [1,2]. This workgroup
utilized previously existing criteria to try and unify and
develop all aspects, both clarified and uncertain, of AKI
and critical care nephrology. The Acute Dialysis Quality
Initiative group had designed the RIFLE (Risk, Injury,
Failure, Loss of function and End-stage kidney disease)
system for diagnosis and classification through a broad
consensus of experts back in 2004 [3]. This classification
was also modified for pediatric patients in order to bet-
ter classify small children with AKI (pediatric RIFLE)
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months following its publication. After this time
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org/publicdomain/zero/1.0/) applies to the data(AKIN) endorsed the RIFLE criteria with a modification
to include changes in serum creatinine (sCr; ≥0.3 mg/dl
or 26.5 μmol/l) when they occur within a 48-hour period
[5]. Unfortunately, the existing criteria, while useful and
widely validated, are still limited by relatively scarce and
non-uniform clinical application [6]. The KDIGO work-
group focused their effort into reconciling all the differ-
ent criteria and providing a comprehensive set of
guidelines and new definitive AKI criteria (Table 1).ate assessment of kidney function in the critically ill pa-
tient plays an important role in diagnosing AKI as well
as ensuring the appropriate prescription and dosing of
drugs and the timely application of therapeutic strat-
egies. sCr is used daily as a marker for kidney function
[7], although it may not be suitable for this purpose as it
is affected by factors other than kidney function. It is
well known that creatinine is metabolized from creatine,
which is released by the muscles; therefore, muscle mass
and metabolic transformation of creatine have an impact
on sCr concentration. In addition, age, gender and race
all affect muscle mass and, in turn, sCr concentrations.
In critically ill patients, creatinine production may be de-
creased because of immobilization and malnutrition or
increased because of catabolic illness. Increases in total
body water, common in these patients, increases the dis-
tribution volume of creatinine and attenuates the in-
crease in sCr caused by AKI. Bragadottir and colleagues
[8] also showed that daily changes in serum creatinine as
a surrogate of glomerular filtration rate poorly reflect
changes in kidney function in patients with AKI. Other
groups have investigated the use of urinary indices, such
as the fractional excretion of sodium and the fractional
excretion of urea (FeUrea), for the differential diagnosis
of different forms of AKI [9-12]. Pons and coworkers [9]
performed a prospective multicenter observational study
enrolling 244 consecutive patients, including 97 without
AKI, 54 with transient AKI and 93 with persistent AKI.
Urinary sodium, urea and creatinine were measured at
ICU admission (H0) and every 6 hours during the firstd. The licensee has exclusive rights to distribute this article, in any medium, for 12
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Table 1 Kidney disease: improving global outcome (KDIGO) classification for acute kidney injury diagnosis
Stage 1 Stage 2 Stage 3
KDIGO (2012) ↑sCr ≥0.3 mg/dl (26.5 μmol/l) within 48 hours ↑sCr >2.0-2.9 × baseline sCr≥ 4.0 mg/dl (353.6 μmol/L)
OR OR OR
1.5-1.9 × baseline within a week UO <0.5 ml/kg/hour for ≥12 hours ↑sCr >3.0 × baseline
OR OR
UO <0.5 ml/kg/hour for 6–12 hours UO <0.3 ml/kg/hour for 24 hours
OR




In patients <18 years old, ↓ in eGFR to
<35 ml/minute/1.73 m2
Up arrows indicate increase; down arrows indicate decrease. eGFR, estimated glomerular filtration rate; RRT, renal replacement therapy; sCr, serum creatinine; UO,
urine output.
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AKI was defined as AKI with a cause for renal hypoper-
fusion and reversal within 3 days. Even though signifi-
cant increases from H0 to H24 were noted in FeUrea
(median 31% (22 to 41%) at H0; 39% (29 to 48%) at H24;
P <0.0001), urinary urea/plasma urea ratio (median 15 (7
to 28) at H0; 20 (9 to 40) at H24; P <0.0001), and urin-
ary creatinine/plasma creatinine ratio (median 50 (24 to
101) at H0; 57 (29 to 104) at H24; P = 0.01), fractional
excretion of sodium did not change significantly during
the first 24 hours in the ICU (P = 0.13). Neither urinary
index values at ICU admission nor changes in urinary
indices between H0 and H24 performed sufficiently well
to recommend their use in the clinical setting of critically
ill patients (area under the receiver operating characteris-
tic curve ≤0.65). This study shows the poor performance
of standard urinary indices at ICU admission for differen-
tiating transient AKI from persistent AKI in unselected
critically ill patients. Although changes over the first
24 hours and values at H24 performed slightly better than
values at admission, their performance remained too low
to be clinically useful. Together with other work [10], this
study raises more fundamental questions about the value,
meaning and pathophysiologic validity of the pre-renal
AKI paradigm and suggests that AKI (like all other forms
of organ injury) is a continuum of injury that cannot be
neatly divided into functional (pre-renal or transient) or
structural (acute tubular necrosis or persistent).
In the near future, biomarkers of renal dysfunction may
identify additional patients with AKI and may identify the
majority of patients at an earlier stage. Among biomarkers
of AKI, the largest body of evidence for the detection of
AKI is related to both urine and plasma neutrophil gelati-
nase associated lipocain (NGAL) [13-15]. Di Somma and
coauthors [16] demonstrated, in a multicenter Italianprospective emergency department cohort study enrolling
665 patients admitted to hospital from the emergency de-
partment, that assessment of a patient’s initial blood
NGAL improved the initial clinical diagnosis of AKI, pre-
dicting the in-hospital mortality. They found that blood
NGAL assessment coupled with the emergency depart-
ment physician’s clinical judgment may prove useful in de-
ciding the appropriate strategies for patients at risk for the
development of AKI.
In a provocative paper, Kashani and colleagues [17]
found that the concentration of two novel markers -
insulin-like growth factor-binding protein 7 and tissue
inhibitor of metalloproteinases-2 - was increased in the
urine of patients at high risk of AKI from a variety of eti-
ologies. These authors then validated these markers in a
separate second phase of their study and compared them
with known markers of AKI such as NGAL and kidney
injury marker-1. Not only did each marker perform bet-
ter than other known markers, but their combination
improved risk stratification when added to a complex
multi-variable clinical model including age, serum cre-
atinine, Acute Physiology and Chronic Health Evaluation
III score, hypertension, nephrotoxic drugs, liver disease,
sepsis, diabetes, and chronic kidney disease. After defini-
tive clinical validation, the application of novel AKI
biomarkers will permit appropriate triage of patients,
more intensive monitoring, and perhaps early involve-
ment of specialists in nephrology and critical care who
can promptly evaluate these patients while they are still
in the golden hours of this disease prior to irreversible
damage to the kidneys. Similar to cardiac troponin, renal
biomarkers are expected in the coming years to allow
timely, bedside, sensitive and specific diagnosis of renal
dysfunction, even in the emergency room. Currently,
however, the ‘renal troponin’ has not been found and
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ical history, routinely available laboratory examinations
and clinical signs, remain the mainstay of AKI diagnosis.
Risk factors and hemodynamics of acute kidney
injury
Kellum and Lameire [1] proposed the concept of risk
factors and susceptibility. The main external stressors
that may cause AKI include sepsis, shock, burns, trauma,
cardiopulmonary bypass, nephrotoxic drugs, radiocon-
trast agents, and poisonous plants and animals. How-
ever, the chances of developing AKI after exposure to
the same insult depend on a number of ‘susceptibility
factors’ that vary widely from individual to individual.
For susceptibility factors we may consider advanced age,
dehydration or volume depletion, female gender, black
race, chronic kidney disease, diabetes mellitus, cancer
and anemia. Therefore, it is important to screen patients
who have undergone an exposure and to continue moni-
toring them until the risk has subsided. To better inter-
pret the pathophysiology of AKI and its interplay with
several hemodynamic variables, a retrospective study
including 137 septic ICU patients was performed [18]:
AKI was defined as occurrence of a novel AKI case or
an increase in the stage of previously diagnosed AKI
during the first 5 days following ICU admission based
on the AKIN criteria. Central venous pressure (CVP),
cardiac output, mean arterial pressure (MAP), diastolic
arterial pressure (DAP), central venous oxygen satur-
ation (ScvO2) or mixed venous oxygen saturation were
analyzed. One-half of patients in the study had new or
persistent AKI. MAP, ScvO2 and cardiac output were
not significantly different between AKI and non-AKI pa-
tients. The development or progression of AKI, regard-
less of the level of fluid balance and positive end-
expiratory pressure, was strongly associated with the
CVP level. This suggests participation of venous conges-
tion in the physiopathology of AKI in severe sepsis and
septic shock. Patients with AKI had lower DAP and
higher CVP (P = 0.0003). Although the role of renal
hypoperfusion (low cardiac output or hypovolemia) is
believed to contribute to the development of sepsis-
induced renal dysfunction, AKI appears to be only
partially reversible after the optimization of systemic
hemodynamics [18]. Fluid resuscitation and pressure
optimization is a landmark treatment for septic patients
in order to improve renal perfusion pressure. For some
patients, the induced CVP elevation may overcome the
DAP increase, reducing renal perfusion with harmful
effects on renal function. This aspect is supported by
the recently reported association between fluid overload
and mortality in critically ill patients, especially in pa-
tients with AKI or septic shock [19]. The creation of a
vicious circle with oliguria and fluid-loading may thenaggravate AKI. Therefore, targeting a pre-defined CVP
as a therapeutic target might not be suitable in septic pa-
tients. Legrand and colleagues suggested instead that
hemodynamic targets are best achieved at low CVPs
(that is, a CVP less than 8 to 12 mmHg) [18]. The Sur-
viving Sepsis Campaign guidelines [20] mention that ‘in
mechanically ventilated patients or those with known
preexisting decreased ventricular compliance, a higher
target CVP of 12–15 mmHg should be achieved to ac-
count for the impediment in filling’. The results of this
study suggest, instead, that such targets might be too
high from a ‘renal’ perspective. Therefore, a strategy of
fluid restriction in these patients is an important option
to be considered.
Poukkanen and coworkers [21] evaluated if a higher
MAP maintained during the first 24 hours of ICU ad-
mission is associated with a lower risk of progression of
AKI in patients with severe sepsis. More than 400 pa-
tients with severe sepsis were enrolled in this prospect-
ive observational study. The primary endpoint was
progression of AKI within the first 5 days of ICU admis-
sion defined as new onset or worsening of AKI by the
KDIGO criteria. AKI progressed in 153 patients (36.2%)
and these patients had significantly lower time-adjusted
MAP (74.4 mmHg (68.3 to 80.8)), than those without
progression (78.6 mmHg (72.9 to 85.4)) (P <0.001).
A cutoff value of 73 mmHg for time-adjusted MAP
best predicted the progression of AKI. These authors
also found that chronic kidney disease, higher lactate,
higher dose of furosemide, use of dobutamine and time-
adjusted MAP below 73 mmHg were independent
predictors of progression of AKI. Interestingly, a more
recent randomized controlled trial assigning septic shock
patients to arms with MAP targets of 80 to 85 mmHg
(high-target group) or 65 to 70 mmHg (low-target
group) found renal outcome differences only in patients
with chronic hypertension [22]. The main difference be-
tween the observational study of Poukkanen and col-
leagues and the prospective SEPSISPAM study is that,
in the first, hypotensive patients were those with the
highest vasopressor loads and, in the second, the high
target group received the largest amount of vasoactive
drugs. It can only be concluded that, possibly, the
underlying septic syndrome severity rather than MAP
or inotropic score is the most important determinant of
renal function.
Outcome
The impact of AKI on long-term clinical outcomes still
remains controversial. Many of the studies evaluating
the outcome of AKI patients come from the cardiac ICU
where the model of AKI has already been well estab-
lished. However, long-term outcomes in a larger setting
of patients still remain to be fully evaluated. For this
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study including 1,030 patients scheduled for acute or
elective cardiac surgery in order to examine the 5-year
risk of death, myocardial infarction, and stroke after
elective cardiac surgery complicated by AKI. AKI was
defined using the AKIN criteria. Patients where followed
from the fifth post-operative day until myocardial infarc-
tion, stroke or death happened within 5 years. A total of
287 (27.9%) of 1,030 patients developed AKI. The 5-year
risk of death was 26.5% (95% confidence interval (CI)
21.2 to 32.0) among patients with AKI and 12.1% (95%
CI 10.0 to 14.7) among patients without AKI. The corre-
sponding adjusted hazard ratio (HR) of death was 1.6
(95% CI 1.1 to 2.2). The 5-year risk of myocardial infarc-
tion was 5.0% (95% CI 2.9 to 8.1) among patients with
AKI and 3.3% (95% CI 2.1 to 4.8) among patients with-
out AKI. The 5-year risk of stroke was 5.0% (95% CI 2.8
to 7.9) among patients with AKI and 4.2% (95% CI 2.9
to 5.8) among patients without AKI. Adjusted HRs were
1.5 (95% CI 0.7 to 3.2) for myocardial infarction and 0.9
(95% CI 0.5 to 1.8) for stroke. AKI within 5 days after
elective cardiac surgery was associated with increased 5-
year mortality but not with increased risk of myocardial
infarction or stroke.
In line with these results the work of Lopez-Delgado and
coworkers [24] evaluated the impact of AKI on short- and
long-term outcome (6.9 ± 4.3 years) after cardiac surgery.
This group prospectively studied 2,940 consecutive cardio-
surgical patients and AKI was defined according to the
modified RIFLE criteria; 14% (n = 409) of the enrolled pa-
tients were diagnosed with AKI. One intra-operative (lon-
ger cardiopulmonary bypass time) and two post-operative
(a longer need for vasoactive drugs and higher arterial lac-
tate level 24 hours after admission) variables were identi-
fied as predictors of AKI. The worst outcomes, including
in-hospital mortality, were associated with the worst RIFLE
class. Kaplan-Meier analysis showed survival of 74.9% in
the RIFLE risk group, 42.9% in the RIFLE injury group and
22.3% in the RIFLE failure group (P <0.001). Classification
at RIFLE injury (HR 2.347, 95% CI 1.122 to 4.907,
P = 0.023) and RIFLE failure (HR 3.093, 95% CI 1.460 to
6.550, P = 0.003) were independent predictors for long-
term patient mortality. These authors concluded that AKI
development after cardiac surgery is associated with post-
operative variables, which ultimately could lead to a worse
RIFLE class. Staging at the RIFLE injury and RIFLE failure
classes is associated with higher short- and long-term mor-
tality in this population. It remains to be ascertained if
these data on AKI patient outcomes may be applicable to
non-cardiac surgery critically ill patients.
Renal replacement therapy
In critically ill patients with AKI, urea and creatinine are
not well performing indicators of renal function giventhe lack of steady state in terms of production and the
influence of catabolism, volume status and production
rates, particularly in sepsis. Consequently, physicians
treating critically ill patients put an increasing emphasis
on fluid overload, oliguria, impaired oxygenation and
acidosis as triggers for initiation of renal replacement
therapy (RRT) with a general trend to initiate RRT earl-
ier in sicker patients. Thakar and colleagues [25] per-
formed an international survey predominantly among
North American nephrologists consulting in the ICU.
They evaluated practice patterns for the initiation of RRT
using three different scenarios representing patients with
increased severity of disease. The majority of the 172 re-
spondents (70% USA) expressed a reticence in commen-
cing RRT early given the lack of evidence, preferring to
base their decision on absolute levels of creatinine or
blood urea nitrogen (BUN) (>442 μmol/l (>5 mg/dl),
>35.6 mmol/l (>100 mg/dl), respectively) rather than any
relative rise. Despite this, 94% of physicians reported that
they would be likely to start dialysis early in patients with
the highest disease burden with early RRT described as a
lower BUN on commencing treatment. Thus, the propor-
tion of physicians starting dialysis at a BUN <75 mg/dl tri-
pled in the more severe case. Finally, given a selection of
five parameters (BUN, creatinine, urine output, oxygen-
ation and potassium) for starting RRT, the latter two were
given the highest priority, with oxygen saturation appear-
ing as the most frequent trigger in severe cases. These re-
sults also differ from a recently published survey among
275, mainly European, intensivists [26]. Whereas the me-
dian thresholds with regard to sCr (300 μmol/l) or urea
(40 mmol/l) were similar, there was a higher priority with
hyperkalemia, metabolic acidosis and volume overload. In
addition, they demonstrated a trend towards early initi-
ation of RRT, with the majority favoring initiation when a
diagnosis of AKI was made based on AKIN/RIFLE criteria,
particularly with regard to oliguria [27]. As usual, it must
be remarked that data from surveys have a high risk of
self-selection of participants; however, these results should
not be overlooked as they represent the view of a large
panel of experts.
Data from observational studies have suggested that
early RRT in critically ill patients with AKI may have a
beneficial impact on survival [28,29]. However, in addition
to the lack of large randomized clinical trials assessing
early RRT indication, there is a broad variation in the cri-
teria used to classify early or late RRT.
For this purpose Leite and coworkers [30], using the
AKIN classification, compared RRT initiation in critic-
ally ill patients, defining early or late RRT in reference to
timing after stage 3 AKIN. Patients beginning RRT
within 24 hours after AKI stage 3 were considered early
starters. AKIN criteria were evaluated by both urine out-
put and sCr. Patients with acute-on-chronic kidney
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critically ill patients were managed with RRT but only
150 patients with AKI at stage 3 were analyzed: mortal-
ity was lower in the early RRT group (51.5 versus 77.9%,
P = 0.001). After achieving balance between the groups
using a propensity score, there was a significant 30.5%
(95% CI 14.4 to 45.2%, P = 0.002) relative decrease of
mortality in the early RRT group. Moreover, patients in
the early RRT group had lower duration of mechanical
ventilation and time on RRT and a trend to lower ICU
length of stay. Although showing promising results in
terms of performing early RRT in critically ill patients,
this study evaluated only AKIN stage 3, so the influence
of RRT on earlier AKI stages was not fully evaluated.
Another limitation is the lack of data on fluid balance,
making it difficult to make conclusions about reduced
mechanical ventilation time in early RRT patients.
Another important aspect investigated in Critical Care
is the choice of the most appropriate modality of renal
replacement therapy for AKI management in critically ill
patients [31]. In current practice many different ap-
proaches are used in the ICU. One basic and important
issue is the frequency of RRT delivery: in terms of hard
outcomes (namely mortality and length of hospital stay)
it has currently not been clarified if dialysis should be
delivered in the ICU in a continuous or intermittent
fashion. The single-center prospective randomized clin-
ical trial Comparing Continuous Versus Intermittent
Hemodialysis in ICU Patients (CONVINT) included 252
critically ill patients with dialysis-dependent AKI [32].
Patients were randomized to receive either daily inter-
mittent hemodialysis (IHD) or continuous veno-venous
hemofiltration (CVVH). The primary outcome measure
was survival at 14 days after the end of RRT. Secondary
outcome measures included 30-day, ICU, and intra-
hospital mortality, as well as course of disease severity/
biomarkers and need for organ-support therapy. Survival
rates at 14 days after RRT were 39.5% (IHD) versus
43.9% (CVVH) (odds ratio 0.84, 95% CI 0.49 to 1.41,
P = 0.50). No differences were observed for days on
RRT, vasopressor days, days on ventilator, or ICU/intra-
hospital length of stay. After the results of this study,
intermittent and continuous RRT may be considered
equivalent approaches for critically ill patients with
dialysis-dependent acute renal failure. As the accom-
panying editorial also commented [31], both modalities
should probably be available in the ICU and the best
option considered each time a patient’s clinical condi-
tion is re-assessed: it is possible that more stable pa-
tients may gain advantage from short sessions of IHD,
whereas those on the critical side of ICU management
(requiring administration of frequent volume boluses or
vasopressor drugs) may still find benefit from continu-
ous RRT (CRRT).Extracorporeal oxygenation/decapneization and
the kidney
The impact of AKI during extracorporeal membrane
oxygenation (ECMO) and the use of CRRT to remove
CO2 during the management of moderate forms of acute
respiratory distress syndrome (ARDS) are two topics
evaluated by expert investigators in the field of critical
care nephrology in 2013.
The impact of AKI in a selected population of children
(neonates) has been well discussed by Zwiers and co-
workers [33] from Rotterdam, Sophia Children’s Hos-
pital. They reviewed 14 years of prospectively collected
clinical data, including age, diagnosis, ECMO course and
sCr of all ECMO-treated neonates within their institu-
tion. ECMO is an advanced extracorporeal technique
providing life support (cardiac and/or respiratory) to pa-
tients with acute reversible respiratory or cardiovascular
failure who are not responding to conventional intensive
care. Zwiers and colleagues used the pediatric RIFLE
categorization to better identify patients suffering from
AKI. This cohort study included 242 critically ill neo-
nates receiving ECMO support, 179 (74%) of whom sur-
vived. In total, 153 (64%) patients had evidence of AKI,
with 72 (30%) qualifying as RIFLE Risk, 55 (23%) as RI-
FLE Injury, and 26 (11%) as RIFLE Failure. At the end of
the study period, only 71 (46%) of the 153 AKI patients
improved by at least one pediatric RIFLE category. Sur-
vival until ICU discharge was significantly lower for pa-
tients in the failure category (35%) compared with the
non-AKI (78%), risk (82%), and injury (76%) categories
(P <0.001), whereas no significant differences were found
between the three latter RIFLE categories. This study did
have some limitations, such as: a) the sCr level is a de-
layed measure of decreased kidney function after AKI
and is not very sensitive; b) the ECMO circuit in neo-
nates doubles the circulating volume, thereby diluting
sCr levels - thus, the true incidence of AKI during the
first days of ECMO treatment is hard to establish; c) the
urine output for grading AKI was not used in this study
and the results acquired could not, therefore, be accur-
ate according to pediatric RIFLE classification. Since
AKI during childhood may predispose to chronic kidney
disease in adulthood, we believe that long-term monitor-
ing of kidney function after neonatal ECMO should be
mandatory. As provocatively addressed in the interesting
accompanying editorial, AKI in the course of multiple
organ dysfunction syndrome (MODS) remains a ‘circular
reference’ [34]: AKI in patients requiring ECMO therapy
is triggered by initial systemic insults, already present
at the time of ECMO initiation, and aggravated by reper-
fusion injury and ECMO circuit-induced inflammation.
The close interplay between the cause and severity
of the disease, supportive therapies, and host response
may significantly influence the development of AKI and
Note: This article is part of a collection of Year in review articles
in Critical Care. Other articles in this series can be found at
http://ccforum.com/series/Yearinreview2013.
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importance of extrinsic factors aggravating MODS/AKI
during ECMO therapy is central: circuit biocompatibil-
ity, monitoring organ ‘reperfusion’ as well as function
(through the implementation of novel organ-specific or
injury-specific biomarkers), and deleterious therapeutic
interventions, such as antimicrobial chemotherapy ad-
ministered in AKI patients without a thorough drug
level control [34].
The second important technological aspect covered in
2013 is the use of CRRT systems coupled with a CO2 re-
moval device for the management of moderate forms of
ARDS. Mechanical ventilation using high tidal volumes and
high airway pressures has been shown to be deleterious for
patient outcomes; thus, protective ventilation strategies, in-
cluding lower tidal volumes, have been implemented in
clinical practice [35]. Although this strategy may lead to re-
spiratory acidosis, a careful and gentle ventilation strategy
with permissive hypercapnia and concomitant slight acid-
osis is presently widely accepted. The exact threshold to
which respiratory acidosis should be tolerated is presently a
matter of debate: in the most severe cases, ECMO and
pumpless extracorporeal lung assist devices are increasingly
used to support lung-protective ventilation strategies and
to improve CO2 removal. Forster and coworkers [35] tried
to assess the effectiveness of a hollow-fiber gas exchanger
integrated into a conventional renal-replacement circuit
on CO2 removal, acidosis and hemodynamics. In 10 venti-
lated critically ill patients with ARDS and AKI undergoing
renal and respiratory support, the effects of low-flow CO2
removal on respiratory acidosis compensation were tested:
CO2 elimination in the low-flow circuit was safe and
was well tolerated by all patients. After 4 hours of treat-
ment, a mean reduction in arterial CO2 of 17.3 mmHg
(−28.1%) was observed, in line with an increase in pH. In
hemodynamically unstable patients, low-flow CO2 elimin-
ation was paralleled by hemodynamic improvement, with
an average reduction of vasopressors of 65% in five of six
catecholamine-dependent patients during the first 24 hours.
Integration of a hollow-fiber gas exchanger could thus po-
tentially be an additional tool in the armamentarium of
treatment modalities in patients with multiorgan failure.
Because no further catheters are needed, besides those
for renal replacement, the implementation of a hollow-
fiber gas exchanger in a renal circuit could be an at-
tractive and minimally invasive therapeutic tool; it
remains to be specified whether the application of these
devices should be limited to patients with mild to mod-
erate ARDS, suffering from prevalently CO2 accumula-
tion and no severe oxygenation defects.
Conclusion
Interesting new ideas were evaluated and addressed
in 2013 in the field of critical care nephrology: newclassification criteria (KDIGO), new promising bio-
markers (insulin-like growth factor-binding protein 7
and tissue inhibitor of metalloproteinases-2), new con-
cepts on timing of RRT and the importance of fluid
overload. Furthermore, current research in this field is
increasingly focusing on the (unfortunately poor) long-
term follow-up of critically ill patients who have suffered
from severe AKI. Finally the continuous implementation
in clinical practice of multiple organ support therapy
(that is, ECMO or decarboxylation devices adapted to a
CRRT platform) further highlights the great develop-
ment of extracorporeal treatments for the care of more
complex and challenging patients.Abbreviations
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